Shares of Anthem, Inc. (NYSE:ANTM) have been assigned a consensus rating of “Buy” from the twenty analysts that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and fourteen have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $393.65.
Several equities analysts have recently weighed in on ANTM shares. BMO Capital Markets lifted their price objective on Anthem from $440.00 to $450.00 and gave the company an “outperform” rating in a research note on Thursday, April 22nd. Royal Bank of Canada lifted their price objective on Anthem from $350.00 to $399.00 and gave the company an “outperform” rating in a research note on Wednesday, April 28th. Argus lifted their price objective on Anthem from $330.00 to $435.00 and gave the company a “buy” rating in a research note on Thursday, May 6th. Stephens boosted their price target on Anthem from $395.00 to $430.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 28th. Finally, Mizuho boosted their price target on Anthem from $320.00 to $380.00 and gave the stock a “neutral” rating in a research report on Monday, May 10th.
In other news, EVP Peter D. Haytaian sold 59,500 shares of the business’s stock in a transaction that occurred on Monday, March 22nd. The stock was sold at an average price of $349.20, for a total value of $20,777,400.00. Following the completion of the sale, the executive vice president now directly owns 59,544 shares in the company, valued at approximately $20,792,764.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Ronald W. Penczek sold 2,068 shares of the business’s stock in a transaction that occurred on Friday, March 5th. The shares were sold at an average price of $333.94, for a total value of $690,587.92. Following the completion of the sale, the chief accounting officer now owns 3,137 shares of the company’s stock, valued at $1,047,569.78. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by insiders.
ANTM traded down $0.27 during midday trading on Monday, hitting $393.66. The company’s stock had a trading volume of 556,743 shares, compared to its average volume of 1,264,085. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.56. The firm has a market cap of $96.38 billion, a P/E ratio of 20.35, a PEG ratio of 0.92 and a beta of 1.00. The firm has a 50-day moving average price of $375.74 and a two-hundred day moving average price of $331.39. Anthem has a 52-week low of $244.10 and a 52-week high of $406.00.
Anthem (NYSE:ANTM) last released its quarterly earnings data on Tuesday, April 20th. The company reported $7.01 earnings per share for the quarter, beating the consensus estimate of $6.86 by $0.15. The business had revenue of $32.10 billion for the quarter, compared to analyst estimates of $32.98 billion. Anthem had a return on equity of 18.45% and a net margin of 4.22%. The company’s revenue was up 9.0% compared to the same quarter last year. During the same period in the previous year, the company posted $6.48 EPS. On average, equities analysts expect that Anthem will post 22.44 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 25th. Shareholders of record on Thursday, June 10th will be given a $1.13 dividend. This represents a $4.52 dividend on an annualized basis and a dividend yield of 1.15%. This is a positive change from Anthem’s previous quarterly dividend of $0.95. The ex-dividend date is Wednesday, June 9th. Anthem’s dividend payout ratio is presently 23.25%.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
Further Reading: What is the role of the G-20?
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.